<DOC>
	<DOCNO>NCT00002851</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy may kill tumor cell remain surgery . PURPOSE : This randomized phase III trial study radiation therapy see well work compare therapy treat woman stage I , stage II , stage III breast cancer surgically remove .</brief_summary>
	<brief_title>Lymph Node Radiation Therapy Patients With Stage I , Stage II , Stage III Breast Cancer That Has Been Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : - Compare effect irradiation homolateral internal mammary medial supraclavicular lymph node chain vs therapy survival , disease-free survival , metastasis-free survival , cause death woman resect stage I/II/III breast cancer . OUTLINE : This randomize , multicenter study . Patients stratify participate institution , tumor location , type prior breast surgery , pathologic T N stage , menopausal status , time sequence radiotherapy adjuvant chemotherapy . Patients randomize 1 2 arm . - Arm I : Patients receive nodal irradiation . - Arm II : Patients receive irradiation internal mammary medial supraclavicular lymph node chain deliver 1 fraction per day , 5 session per week , total 25 fraction 5 week . Radiotherapy must begin later 8 week surgery . If adjuvant chemotherapy give , radiotherapy begin within 6 week last course chemotherapy within 8 month surgery . Patients follow least yearly randomization 20 year . PROJECTED ACCRUAL : A total 4,000 patient accrue study within 4 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unilateral adenocarcinoma breast Stage I/II/III ( Tx , T03 , N02 ) disease one follow category multifocal tumor one foci agreement follow : Centrally medially locate lymph node status Central location define underlying areola Medial location define least partial involvement upper low medial quadrant breast Externally locate axillary node involvement Prior mastectomy breastconserving surgery axillary dissection require Sentinel node procedure axillary intervention without axillary surgery allow No prior internal mammary chain dissection No upper inner lesion treat breastconserving surgery precludes spar internal mammary lymph node chain radiotherapy volume Decision radiation oncologist 's discretion Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 75 Sex : Female Menopausal status : Not specify Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No prior cardiac disease Other : No prior malignancy except adequately treat nonmelanomatous skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics Other : Concurrent enrollment randomize trial allow</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>